PortfoliosLab logoPortfoliosLab logo
Humana Inc. (HUM)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US4448591028
CUSIP
444859102
IPO Date
Jan 22, 1993

Highlights

Market Cap
$20.87B
Enterprise Value
$29.03B
EPS (TTM)
$9.85
PE Ratio
17.60
Total Revenue (TTM)
$129.66B
Gross Profit (TTM)
$97.15B
EBITDA (TTM)
$2.92B
Year Range
$163.11 - $315.35
Target Price
$277.50
ROA (TTM)
2.43%
ROE (TTM)
6.73%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Humana Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Humana Inc. (HUM) has returned -31.96% so far this year and -33.44% over the past 12 months. Over the last ten years, HUM has returned 0.21% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Humana Inc.

1D
4.45%
1M
-8.54%
YTD
-31.96%
6M
-32.79%
1Y
-33.44%
3Y*
-28.19%
5Y*
-15.10%
10Y*
0.21%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 22, 1993, HUM's average daily return is +0.07%, while the average monthly return is +1.26%. At this rate, your investment would double in approximately 4.6 years.

Historically, 57% of months were positive and 43% were negative. The best month was Jul 2000 with a return of +50.0%, while the worst month was Mar 1993 at -59.4%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HUM closed higher 50% of trading days. The best single day was May 29, 2015 with a return of +20.3%, while the worst single day was Mar 8, 1993 at -65.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-23.79%-2.39%-8.54%-31.96%
202515.58%-7.78%-1.83%-0.89%-11.10%5.26%2.20%21.53%-14.02%6.93%-11.65%4.57%2.36%
2024-17.42%-7.34%-0.78%-12.87%18.55%4.59%-3.22%-1.97%-10.40%-18.60%14.95%-14.10%-43.96%
2023-0.10%-3.26%-1.75%9.28%-5.40%-10.73%2.17%1.05%5.58%7.64%-7.41%-5.39%-9.94%
2022-15.38%10.65%0.38%2.16%2.18%3.22%2.98%-0.05%0.87%15.02%-1.47%-6.72%11.15%
2021-6.62%-0.90%10.61%6.20%-1.69%1.31%-3.81%-4.80%-3.84%19.02%-9.38%10.68%13.80%

Benchmark Metrics

Humana Inc. has an annualized alpha of 9.60%, beta of 0.76, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since January 25, 1993.

  • This stock participated in 72.42% of S&P 500 Index downside but only 69.50% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
9.60%
Beta
0.76
0.11
Upside Capture
69.50%
Downside Capture
72.42%

Return for Risk

Risk / Return Rank

HUM ranks 13 for risk / return — in the bottom 13% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


HUM Risk / Return Rank: 1313
Overall Rank
HUM Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
HUM Sortino Ratio Rank: 1515
Sortino Ratio Rank
HUM Omega Ratio Rank: 1414
Omega Ratio Rank
HUM Calmar Ratio Rank: 1616
Calmar Ratio Rank
HUM Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Humana Inc. (HUM) and compare them to a chosen benchmark (S&P 500 Index).


HUMBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.68

0.90

-1.57

Sortino ratio

Return per unit of downside risk

-0.73

1.39

-2.11

Omega ratio

Gain probability vs. loss probability

0.90

1.21

-0.31

Calmar ratio

Return relative to maximum drawdown

-0.71

1.40

-2.11

Martin ratio

Return relative to average drawdown

-1.47

6.61

-8.08

Explore HUM risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Humana Inc. provided a 2.04% dividend yield over the last twelve months, with an annual payout of $3.54 per share. The company has been increasing its dividends for 9 consecutive years.


0.40%0.60%0.80%1.00%1.20%1.40%$0.00$1.00$2.00$3.00$4.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$3.54$3.54$3.54$3.54$3.15$2.80$2.50$2.20$2.00$1.89$0.87$1.15

Dividend yield

2.04%1.38%1.40%0.77%0.62%0.60%0.61%0.60%0.70%0.76%0.43%0.64%

Monthly Dividends

The table displays the monthly dividend distributions for Humana Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.89$0.89
2025$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2024$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2023$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2022$0.00$0.00$0.79$0.00$0.00$0.79$0.00$0.00$0.79$0.00$0.00$0.79$3.15
2021$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.70$2.80

Dividend Yield & Payout


Dividend Yield

Humana Inc. has a dividend yield of 2.04%, which is quite average when compared to the overall market.

Payout Ratio

Humana Inc. has a payout ratio of 36.11%, which is quite average when compared to the overall market. This suggests that Humana Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Humana Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Humana Inc. was 85.10%, occurring on Jun 16, 2000. Recovery took 1149 trading sessions.

The current Humana Inc. drawdown is 67.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-85.1%Jul 2, 1998495Jun 16, 20001149Jan 13, 20051644
-78.42%Jan 15, 2008287Mar 5, 2009674Nov 3, 2011961
-69.92%Nov 4, 2022839Mar 12, 2026
-68.82%Feb 11, 199343Apr 14, 1993205Feb 2, 1994248
-45.67%Feb 14, 1996105Jul 15, 1996472May 28, 1998577

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Humana Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Humana Inc. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HUM, comparing it with other companies in the Healthcare Plans industry. Currently, HUM has a P/E ratio of 17.6. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HUM relative to other companies in the Healthcare Plans industry. Currently, HUM has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HUM in comparison with other companies in the Healthcare Plans industry. Currently, HUM has a P/B value of 1.2. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items